| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |